SF News Global Supplement News Engine
Science

Adaptogens: What They Are, Whether They Work, and Which Is Best for You

From ashwagandha to rhodiola, reishi to lion's mane — a science-first assessment of whether adaptogens deliver on their promises for stress, cognition, and performance.

AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →

Science concept image

London, United Kingdom — 31 March 2026

Adaptogens have become one of the most discussed ingredient categories in the supplement industry. From ashwagandha lattes to rhodiola-infused pre-workouts, these botanicals are marketed as stress-busters, performance enhancers, and mood stabilisers. But what does the evidence actually say?

What Are Adaptogens?

Adaptogens are a class of herbs and mushrooms that are proposed to help the body resist physical, chemical, and biological stressors. The term was coined in 1947 by Soviet toxicologist Nikolai Lazarev, and the concept was later refined by Israel Brekhman. To qualify as an adaptogen, a substance must be non-toxic at normal doses, produce a non-specific defensive response, and have a normalising effect on physiology.

The most widely studied adaptogens include ashwagandha (Withania somnifera), rhodiola (Rhodiola rosea), holy basil (Ocimum tenuiflorum), eleuthero (Eleutherococcus senticosus), schisandra (Schisandra chinensis), and medicinal mushrooms such as reishi, lion's mane, and cordyceps.

Do Adaptogens Actually Work?

The evidence is promising but uneven. Ashwagandha has the strongest clinical backing, with multiple randomised controlled trials demonstrating significant reductions in serum cortisol and self-reported stress scores. A 2019 systematic review in the Journal of Alternative and Complementary Medicine found that ashwagandha supplementation reduced anxiety scores by an average of 44% compared to placebo.

Rhodiola rosea has shown benefits for fatigue and mild-to-moderate depression in several European clinical trials, though sample sizes remain small. Reishi and cordyceps mushrooms have demonstrated immunomodulatory and anti-fatigue properties in preclinical models, but human data is limited. Lion's mane shows exciting potential for cognitive support through nerve growth factor stimulation, though large-scale trials are still needed.

Which Adaptogen Is Best?

There is no single "best" adaptogen — the optimal choice depends on the desired outcome. For stress and anxiety, ashwagandha (particularly the KSM-66 extract at 600 mg/day) has the most robust evidence. For physical performance and fatigue, rhodiola rosea (200–600 mg/day standardised to 3% rosavins) is the strongest candidate. For cognitive function, lion's mane (500–3000 mg/day) is the most researched. For immune modulation, reishi (1.5–9 g/day of dried mushroom equivalent) is the traditional choice.

How Long Do Adaptogens Take to Work?

Unlike pharmaceutical anxiolytics that act within hours, adaptogens typically require consistent daily use over 4–8 weeks before measurable benefits emerge. Ashwagandha studies generally report significant cortisol reductions by week 4, with peak effects at 8–12 weeks. Rhodiola may produce noticeable anti-fatigue effects somewhat faster, within 1–3 weeks for some users, though full benefits accumulate over longer periods.

Are Adaptogens Safe?

At recommended doses, the major adaptogens have favourable safety profiles. Ashwagandha is generally well tolerated, though rare cases of liver injury have been reported — the European Food Safety Authority flagged this in a 2023 review. Rhodiola can cause mild dizziness or dry mouth. Medicinal mushrooms are broadly safe but may interact with immunosuppressive medications. Pregnant or breastfeeding women should avoid most adaptogens due to insufficient safety data.

Quality control is a real concern: a 2022 analysis found that 30% of ashwagandha products tested contained withanolide levels significantly different from label claims. Consumers should look for third-party tested products with standardised extract concentrations.

Can You Stack Adaptogens?

Stacking — combining multiple adaptogens — is common in traditional Ayurvedic and Chinese medicine systems. Modern supplement brands frequently combine ashwagandha with rhodiola, or blend medicinal mushrooms together. While there is limited clinical research on specific stacking protocols, the practice is generally considered safe provided each individual ingredient is dosed within its recommended range. The theoretical rationale is that different adaptogens act through complementary mechanisms: ashwagandha primarily modulates the HPA axis, while rhodiola acts more on monoamine neurotransmitters.

When Should You Take Adaptogens?

Timing depends on the specific adaptogen and desired effect. Ashwagandha is typically taken with meals, often in the evening due to its calming properties — though morning dosing is also effective. Rhodiola is best taken in the morning or early afternoon, as its stimulating qualities may interfere with sleep if taken late. Lion's mane can be taken at any time but is often consumed in the morning for cognitive support. Consistency matters more than precise timing.

Adaptogens for Stress and Anxiety: What the Research Shows

Chronic stress is the primary use case driving adaptogen sales globally. The hypothalamic-pituitary-adrenal (HPA) axis — the body's central stress response system — is the main pharmacological target. Ashwagandha has been shown to reduce cortisol levels by 23–30% in clinical trials. Rhodiola appears to work partly by modulating cortisol and partly by increasing serotonin and dopamine precursor availability. Holy basil (tulsi) has demonstrated anxiolytic effects in several Indian clinical trials, reducing generalised anxiety disorder symptoms by approximately 39% versus placebo.

Are Adaptogens Just a Trend?

The commercial hype around adaptogens is undeniable — the global adaptogen market is projected to exceed $16 billion by 2028. However, the underlying science, while incomplete, is not trivial. Ashwagandha and rhodiola in particular have decades of clinical investigation behind them. The risk is not that adaptogens are useless, but that overclaiming and poor-quality products undermine legitimate science. For B2B supplement manufacturers, the opportunity lies in evidence-backed formulations with transparent dosing — not in trend-chasing with fairy-dust sprinkles of underdosed ingredients.

Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.